Background There is a need for early markers to track and predict the development of type 2
diabetes mellitus (T2DM) from the state of normal glucose tolerance through prediabetes. In …

We identify biomarkers for disease progression in three type 2 diabetes cohorts encompassing
2,973 individuals across three molecular classes, metabolites, lipids and proteins. …

Aims/hypothesis Five clusters based on clinical characteristics have been suggested as
diabetes subtypes: one autoimmune and four subtypes of type 2 diabetes. In the current study …

There is an urgent need for a better molecular understanding of the pathophysiology underlying
development and progression of diabetic nephropathy. The aim of the current study was …

Introduction A critical and as-yet unmet need in Alzheimer's disease (AD) is the discovery of
peripheral small molecule biomarkers. Given that brain pathology precedes clinical …

Background The molecular mechanisms mediating postnatal loss of cardiac regeneration in
mammals are not fully understood. We aimed to provide an integrated resource of mRNA , …

Omics-based methods may provide new markers associated to diabetic retinopathy (DR). We
investigated a wide omics panel of metabolites and lipids related to DR in type 1 diabetes. …

Type 2 diabetes is a multifactorial disease with multiple underlying aetiologies. To address
this heterogeneity, investigators of a previous study clustered people with diabetes according …

Background: Improved understanding of the pathophysiology causing diabetic kidney disease
(DKD) is imperative. The aim of this study was to uncover associations between serum …

Aims/hypothesis Abnormal gut microbiota and blood metabolome profiles have been reported
both in children and adults with uncomplicated type 1 diabetes as well as in adults with …